Physician profile
Thomas Michael Cox
NPI 1770998007
$11,678.91
in general payments reported to CMS, 2019-2025
10 companies · $32.21 in 2025
The $32.21 reported for 2025 was less than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $298 · 2020: $11K · 2021: $81.71 · 2022: $141 · 2023: $66.54 · 2025: $32.21.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $98.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $98.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,938.20 | 2020-2022 | |
| Stryker Corporation | $297.76 | 2019 | |
| Zimmer Biomet Holdings, INC. | $132.15 | 2020 | |
| Acell, INC. | $123.85 | 2020 | |
| Teleflex LLC | $40.20 | 2022 | |
| Depuy Synthes Sales INC. | $36.26 | 2021 | |
| Integra Lifesciences Corporation | $32.21 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $31.74 | 2022-2023 | Grafix Pl |
| Kerecis Limited | $25.03 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Csl Behring | $21.51 | 2023 | Kcentra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.